122 related articles for article (PubMed ID: 15927706)
1. Functional expression of neuropeptide Y receptors in human neuroblastoma cells.
Li AJ; Ritter S
Regul Pept; 2005 Jul; 129(1-3):119-24. PubMed ID: 15927706
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
Spinazzi R; Andreis PG; Nussdorfer GG
Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
Dhillon SS; Gingerich S; Belsham DD
Regul Pept; 2009 Aug; 156(1-3):96-103. PubMed ID: 19371763
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
Umeda T; Kanatani A; Iwaasa H
Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
[TBL] [Abstract][Full Text] [Related]
6. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM
Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577
[TBL] [Abstract][Full Text] [Related]
8. Insulin directly regulates NPY and AgRP gene expression via the MAPK MEK/ERK signal transduction pathway in mHypoE-46 hypothalamic neurons.
Mayer CM; Belsham DD
Mol Cell Endocrinol; 2009 Aug; 307(1-2):99-108. PubMed ID: 19524132
[TBL] [Abstract][Full Text] [Related]
9. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
[TBL] [Abstract][Full Text] [Related]
10. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells.
Rosmaninho-Salgado J; Araújo IM; Alvaro AR; Duarte EP; Cavadas C
J Neurochem; 2007 Nov; 103(3):896-903. PubMed ID: 17868303
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of neuropeptide Y-mediated calcium responses in human SMS-KAN neuroblastoma cells endogenously expressing Y2 receptors by co-expression of chimeric G proteins.
Dautzenberg FM
Biochem Pharmacol; 2005 May; 69(10):1493-9. PubMed ID: 15857613
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide-Y family of peptides in the autocrine-paracrine regulation of adrenocortical function.
Nussdorfer GG; Gottardo G
Horm Metab Res; 1998; 30(6-7):368-73. PubMed ID: 9694565
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
Gehlert DR; Schober DA; Morin M; Berglund MM
Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic regulation of neuropeptide Y synthesis and release in human neuroblastoma cells.
Dozio E; Ruscica M; Feltrin D; Motta M; Magni P
Peptides; 2008 Mar; 29(3):491-5. PubMed ID: 18155321
[TBL] [Abstract][Full Text] [Related]
16. Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet.
Wang C; Yang N; Wu S; Liu L; Sun X; Nie S
Horm Metab Res; 2007 Apr; 39(4):262-7. PubMed ID: 17447163
[TBL] [Abstract][Full Text] [Related]
17. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of neuroblastoma subtypes in response to mitogen-activated protein kinase inhibition: profiling multiple targets of cancer kinase signaling.
Sandoval JA; Eppstein AC; Hoelz DJ; Klein PJ; Linebarger JH; Turner KE; Rescorla FJ; Hickey RJ; Malkas LH; Schmidt CM
J Surg Res; 2006 Jul; 134(1):61-7. PubMed ID: 16650873
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors.
Kitlinska J; Abe K; Kuo L; Pons J; Yu M; Li L; Tilan J; Everhart L; Lee EW; Zukowska Z; Toretsky JA
Cancer Res; 2005 Mar; 65(5):1719-28. PubMed ID: 15753367
[TBL] [Abstract][Full Text] [Related]
20. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist.
Jois SD; Nagarajarao LM; Prabhakaran M; Balasubramaniam A
J Biomol Struct Dyn; 2006 Apr; 23(5):497-508. PubMed ID: 16494499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
